Panbela Therapeutics, Inc. PBLA

Full chart Compare
Set alert

Price alert · PBLA

All alert types
0.01 USD 0.00 (+0.00%)

At closeNov 3, 2026, 4:00 PM EST

0.02 Day range 0.02
0.0001 52-week range 2.50
YTD
+5,450.00%
1 year
-44.50%

Analyst view

Consensus: buy

Buy
Price target (mean) 410.00 +3693593.7% upside
Target (low)
320.00
Target (mean)
410.00
Target (high)
500.00
Ratings (-1m) 2 2 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • 1 month ago 2
  • 2 months ago 2
  • 3 months ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

PBLA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-24.34-28.40 – -20.28-3,408.00+99.3%00.0%2
Next quarter-1.48-1.48 – -1.48-390.00+99.6%00.0%1
Current year-203.86-213.13 – -194.60-40,746.00+99.5%00.0%2
Next year-34.38-63.80 – -4.97-203.86+83.1%00.0%2

Upgrades and downgrades

The latest rating changes

PBLA analyst upgrades and downgrades
DateFirmActionFromTo
Aug 10, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jul 23, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jul 9, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 12, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 1, 2023HC Wainwright & Co.Reiterated—Buy